Author: Nichols Martin|| Date Published: May 4, 2021
Marlborough, Massachusetts-based medical technology company Hologic will supply COVID-19 diagnostic tools to the U.S. Army under a three-year, $178.5 million contract.
The Army’s Health Contracting Activity ordered Panther Fusion and Aptima SARS-CoV-2 assays, multiplex test kits and various related consumable items through the firm-fixed-price contract, the Department of Defense said Monday.
Panther Fusion is an in vitro diagnostic system designed to confirm the presence of RNA from SARS-CoV-2 from upper respiratory specimens.
Aptima multitest kits are intended to help clinicians collect throat and nasal swab specimens for use in company-built coronavirus detection technology.
The Food and Drug Administration granted emergency use authorization to Hologic’s testing products.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…
